Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: A proton magnetic resonance spectroscopy study of the anterior cingulate cortex

Journal of Affective Disorders

Volumn 99, Issue 1-3, 2007, Pages 19-25

  Moore, Constance M ^a,c   Biederman, Joseph ^b,c   Wozniak, Janet ^b,c   Mick, Eric ^b,c   Aleardi, Megan ^b   Wardrop, Megan ^a   Dougherty, Meghan ^b   Harpold, Terri ^b,c   Hammerness, Paul ^b,c   Randall, Edin ^b   Lyoo, In Kyoon ^a,c   Renshaw, Perry F ^a,c  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Anterior cingulate cortex; Bipolar disorder; Glutamate glutamine; Mania; Proton magnetic resonance spectroscopy

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CREATINE; GLUTAMIC ACID; GLUTAMINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADOLESCENT; ARTICLE; BIPOLAR DISORDER; CGI MANIA SCORE; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MANIA; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIPOLAR DISORDER; CHILD; COMORBIDITY; CREATINE; CROSS-SECTIONAL STUDIES; FEMALE; GLUTAMIC ACID; GLUTAMINE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PSYCHIATRIC STATUS RATING SCALES; RISPERIDONE;

EID: 33847052084     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.08.023     Document Type: Article

References (33)

1. Altshuler L., Bookheimer S., Proenza M.A., Townsend J., Sabb F., Firestine A., Bartzokis G., Mintz J., Mazziotta J., and Cohen M.S. Increased amygdala activation during mania: a functional magnetic resonance imaging study. American Journal of Psychiatry 162 (2005) 1211-1213
2. Biederman J., Mick E., Wozniak J., Aleardi M., Spencer T., and Faraone S.V. An open-label trial of risperidone in children and adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology 15 (2005) 311-317
3. Blumberg H.P., Leung H.C., Skudlarski P., Lacadie C.M., Fredericks C.A., Harris B.C., Charney D.S., Gore J.C., Krystal J.H., and Peterson B.S. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Archives of General Psychiatry 60 (2003) 601-609
4. Blumberg H.P., Donegan N.H., Sanislow C.A., Collins S., Lacadie C., Skudlarski P., Gueorguieva R., Fulbright R.K., Mcglashan T.H., Gore J.C., and Krystal J.H. Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder. Psychopharmacology 183 (2005) 308-313
5. Carrey N., Macmaster F.P., Sparkes S.J., Khan S.C., and Kusumakar V. Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. Journal of Child and Adolescent Psychopharmacology 12 (2002) 331-336
6. Chang K.D., and Ketter T.A. Mood stabilizer augmentation with olanzapine in acutely manic children. Journal of Child and Adolescent Psychopharmacology 10 (2000) 45-49
7. Chang K., Adleman N.E., Dienes K., Simeonova D.I., Menon V., and Reiss A. Anomalous prefrontal-subcortical activation in familial pediatric bipolar disorder: a functional magnetic resonance imaging investigation. Archives of General Psychiatry 61 (2004) 781-792
8. Cooper J., Bloom F., and Roth R. Amino Acid Transmitters. 8th ed. The Biochemocal Basis of Neuropharmacology (2003), Oxford University Press, New York
9. Courvoisie H., Hooper S.R., Fine C., Kwock L., and Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. Journal of Neuropsychiatry, Clinical Neuroscience 16 (2004) 63-69
10. Delbello M.P., Schwiers M.L., Rosenberg H.L., and Strakowski S.M. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry 41 (2002) 1216-1223
11. Evins A.E., Amico E.T., Shih V., and Goff D.C. Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics. Journal of Neural Transmission 104 (1997) 761-766
12. Geller B., Fox L.W., and Clark K.A. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. Journal of the American Academy of Child and Adolescent Psychiatry 33 (1994) 461-468
13. Goff D.C., and Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry 158 (2001) 1367-1377
14. Goff D.C., Hennen J., Lyoo I.K., Tsai G., Wald L.L., Evins A.E., Yurgelun-Todd D.A., and Renshaw P.F. Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine. Biological Psychiatry 51 (2002) 493-497
15. Gruber S.A., Rogowska J., and Yurgelun-Todd D.A. Decreased activation of the anterior cingulate in bipolar patients: an fMRI study. Journal of Affective Disorders 82 (2004) 191-201
16. 13C NMR spectroscopy of the brain. NMR in Biomedicine 16 (2003) 313-338
17. Heresco-Levy U. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality. Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 (2003) 1113-1123
18. Huppi P.S., Fusch C., Boesch C., Burri R., Bossi E., Amato M., and Herschkowitz N. Regional metabolic assessment of human brain during development by proton magnetic resonance spectroscopy in vivo and by high-performance liquid chromatography/gas chromatography in autopsy tissue. Pediatric Research 37 (1995) 145-150
19. Kikinis R., Shenton M.E., Gerig G., Martin J., Anderson M., Metcalf D., Guttmann C.R., Mccarley R.W., Lorensen W., Cline H., et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. Journal of Magnetic Resonance Imaging 2 (1992) 619-629
20. 13C nuclear magnetic resonance spectroscopy: elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. Journal of Neuroscience 22 (2002) 1523-1531
21. Lewinsohn P.M., Klein D.N., and Seeley J.R. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. Journal of the American Academy of Child and Adolescent Psychiatry 34 (1995) 454-463
22. Macmaster F.P., Carrey N., Sparkes S., and Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biological Psychiatry 53 (2003) 184-187
23. Mclean M.A., Woermann F.G., Barker G.J., and Duncan J.S. Quantitative analysis of short echo time (1)H-MRSI of cerebral gray and white matter. Magnetic Resonance in Medicine 44 (2000) 401-411
24. Novotny Jr. E.J., Fulbright R.K., Pearl P.L., Gibson K.M., and Rothman D.L. Magnetic resonance spectroscopy of neurotransmitters in human brain. Annals of Neurology 54 Suppl 6 (2003) S25-S31
25. Ongur D., Drevets W.C., and Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 13290-13295
26. 1H spectra with LCModel. NMR in Biomedicine 14 (2001) 260-264
27. Rajkowska G., Halaris A., and Selemon L.D. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49 (2001) 741-752 (see comment)
28. Renshaw P.F., Lafer B., Babb S.M., Fava M., Stoll A.L., Christensen J.D., Moore C.M., Yurgelun-Todd D.A., Bonello C.M., Pillay S.S., Rothschild A.J., Nierenberg A.A., Rosenbaum J.F., and Cohen B.M. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 41 (1997) 837-843
29. Rosenberg D.R., Macmaster F.P., Mirza Y., Smith J.M., Easter P.C., Banerjee S.P., Bhandari R., Boyd C., Lynch M., Rose M., Ivey J., Villafuerte R.A., Moore G.J., and Renshaw P. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biological Psychiatry 58 (2005) 700-704
30. Russell V.A. Dopamine hypofunction possibly results from a defect in glutamate-stimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder - the spontaneously hypertensive rat. Neuroscience and Biobehavioral Reviews 27 (2003) 671-682
31. Sanacora G., Rothman D.L., Mason G., and Krystal J.H. Clinical studies implementing glutamate neurotransmission in mood disorders. Annals of the New York Academy of Sciences 1003 (2003) 292-308
32. Strakowski S.M., Adler C.M., Holland S.K., Mills N.P., Elbello M.P., and Eliassen J.C. Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. American Journal of Psychiatry 162 (2005) 1697-1705
33. Woo T.U., Walsh J.P., and Benes F.M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-d-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Archives of General Psychiatry 61 (2004) 649-657